Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 4/20 | 0.42 |
| ▸ | CTSS | P25774 | 5/20 | 0.42 |
| ▸ | CTSK | P43235 | 4/20 | 0.42 |
| ▸ | CTSL | P07711 | 2/20 | 0.42 |
| ▸ | CTSB | P07858 | 2/20 | 0.42 |
| ▸ | CCKBR | P32239 | 3/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5966595 | 1.00 | REN (0.42) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966560 | 0.87 | REN (0.47) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966544 | 0.87 | REN (0.49) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966478 | 0.85 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966530 | 0.83 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966532 | 0.83 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966487 | 0.81 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966490 | 0.81 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966554 | 0.80 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL5966556 | 0.80 | CTSS (0.51) | RENCTSSCTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2006-06-15 | — | — | US | disclosed |
| EP-1409540-A2 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-04-21 | — | — | EP | disclosed |
| WO-2002026774-A2 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | MC3R, MC4R, MC1R | REN 257/4885CTSS 2475/4885CTSK 3132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.